U.S. Should Create Cost-Effectiveness Group To Advise CMS – NEJM Editorial
Executive Summary
The U.S. government should establish an entity similar to the U.K.'s National Institute for Clinical Excellence to help CMS apply cost-effectiveness criteria to coverage and payment decisions, an editorial in the Oct. 6 New England Journal of Medicine states.
You may also be interested in...
To Get The Most Out Of Health CER, Hire A Mathematician, Conferees Say
Economists, mathematicians and behavioral scientists are among the non-health care specialists who could be essential to ensuring the wealth of comparative effectiveness research data available is used to its full potential, according to speakers at a recent CER event.
PhRMA’s Evidence-Based Medicine Principles Emphasize Individual Decisions
The Pharmaceutical Research & Manufacturers of America's principles for the use of evidence-based medicine emphasize that such data be used to "empower" patients and physicians
P&T Cmtes. Need Incentives To Use Cost-Effectiveness Analyses – MedPAC
Medicare prescription drug plan pharmacy & therapeutics committees should be given incentives for using cost-effectiveness analyses to develop formularies, Medicare Payment Advisory Commission member Alan Nelson suggested during a March 12 meeting in Washington D.C